The U.K. competition regulator said it could approve Synopsys’s $35 billion purchase of Ansys after the companies offered to ...

The giant batteries will operate for two hours at a time before being depleted. Work on the first phase started in November ...

Here are some of the drugs that are predicted to become blockbusters in the next few years, according to Clarivate's latest ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

The New York company is hoping to enter the GLP-1RA space with its newest offering requiring dosing every month over ...

First Tee Northern Nevada broke ground Monday on the nextchapter for Wildcreek Golf Course, which includes a new golf and ...

Employee residents are ‘Weavers’ and corporations are ‘Inventors’ in the new village near Mount Fuji.

Metsera has linked its GLP-1 drug candidate to weight loss of up to 11.3% after 12 weeks, encouraging the biotech to use some ...

Rising Telegram game Zoo tasks players with creating their own animal amusement park—while earning towards an upcoming crypto ...

Blueprint Medicines' Ayvakit shows strong revenue growth, projected to reach over $2 billion in peak sales. Read my analysis ...

With the stock trading for about 17 times the company's full-year free-cash-flow guidance, IBM is a top AI agent stock that ...

Enliven Therapeutics' ELVN-001 shows promising results for CML patients. Click here to read what makes ELVN stock a ...